Liquid NyQuil Recalled Due to Insanitary Conditions at Distribution Center
Gold Star Distribution Inc recalls all lots of Liquid NyQuil (regular and cherry, 12/8oz bottles) distributed nationwide due to insanitary conditions and rodent exposure at their distribution facility.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall with no reported illnesses or injuries. While CGMP deviations involving insanitary conditions and rodent exposure represent a potential contamination risk, the absence of reported harm and the Class II designation indicate this is a precautionary recall.
Plain-English summary
Liquid NyQuil products in regular and cherry flavors (12/8oz bottles) are being recalled by Gold Star Distribution Inc due to Current Good Manufacturing Practice (CGMP) deviations discovered at their distribution center.
Insanitary conditions, including evidence of rodent exposure and activity, were identified at the facility. All lots of the product currently within expiration dating and distributed by Gold Star Distribution are included in this recall.
The recalled products were distributed to consumers nationwide. If you have purchased Liquid NyQuil, you should stop using it and contact Gold Star Distribution Inc for instructions on how to return or dispose of the product.
The recalled product
- Product
- LIQUID NYQUIL a) regular, 12/8oz; b) cherry, 12/8oz
- Manufacturer
- GOLD STAR DISTRIBUTION INC
- Hazard
- sanitation-violation
- rodent-exposure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry distributed by Gold Star Distribution.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27